Point72 Hong Kong LTD Madrigal Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $67,420 - $88,623	-932 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $40,193 - $53,875	-513 Reduced 35.5%	932 $74,000
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $140,454 - $198,817	1,445 New	1,445 $141,000
Q1 2021 May 17, 2021	SELL	$108.54 - $125.2 $26,700 - $30,799	-246 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$110.06 - $133.7 $27,074 - $32,890	246 New	246 $27,000
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $8,581 - $10,682	-86 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $5,171 - $10,811	86 New	86 $10,000
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $2,403 - $3,365	-36 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $3,034 - $4,266	36 New	36 $3,000

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.24B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.